KYTX
Kyverna Therapeutics Inc.
$7.09
-$0.35(-4.70%)
66
Overall
60
Value
72
Tech
--
Quality
Market Cap
$299.26M
Volume
451.80K
52W Range
$1.78 - $8.45
Target Price
$24.00
EPS Estimates Overview
| Current Quarter | $-0.89 | Next Quarter | $-0.96 |
| Current Year | $-3.79 | Next Year | $-3.42 |
| QoQ Growth | -7.9% | YoY Growth | +9.8% |
| 3Y EPS CAGR | +77.1% | Target Price | $24.00 |
| Consensus | Buy | Upside | +238.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $7.09 | -4.7% | 451.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW